Effects of selenite on estrogen, receptor-α expression activity in MCF-7 breast cancer cells

Journal of Cellular Biochemistry

Volumn 79, Issue 2, 2000, Pages 282-292

  Stoica, Adriana ^a   Pentecost, Elizabeth ^a   Martin, Mary Beth ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; ER ; Estradiol; Selenite

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MESSENGER RNA; PROGESTERONE RECEPTOR; SELENITE;

ARTICLE; BINDING AFFINITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; HORMONE BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; COS CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HUMANS; PROTEIN BINDING; PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SODIUM SELENITE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033799762     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20001101)79:2<282::AID-JCB110>3.0.CO;2-V     Document Type: Article

References (57)

1. Observations on the use of plasma, hair and tissue to evaluate trace element status in cancer
2. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha
3. Molecular basis of agonism and antagonism in the estrogen receptor
4. High-efficiency transformation of mammalian cells by plasmid DNA
5. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin
6. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
7. The nutritional biochemistry of selenium
8. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites
9. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: Results from a prospective study in Columbia, Missouri
10. Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes
11. Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials
12. Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium
13. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells
14. An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis
15. Plasma selenium level in cancer patients
16. A prospective study of selenium status and breast cancer risk
17. The chemopreventive role of selenium in carcinogenesis
18. Anticarcinogenic effect of selenium in rats treated with dimethylbenz(a)anthracene and fed different levels and types of fat
19. Chemical form of selenium, critical metabolites, and cancer prevention
20. Serum micronutrients and risk of cancers of low incidence in Finland
21. Mode of action of selenium inhibition of 7,12-dimethylbenz anthracene-induced mouse mammary tumorigenesis
22. Proposed mechanism for selenium-inhibition of mammary tumorigenesis
23. Different patterns of regulation of the genes encoding the closely related 56 kDa selenium-and acetaminophen-binding proteins in normal tissues and during carcinogenesis
24. Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line
25. Towards chemically-defined, serum-free media for mammalian cell culture
26. Mechanisms of selenium inhibition of tumorigenesis
27. Selenium-mediated inhibition of mouse mammary tumorigenesis
28. Effect of dietary selenium levels on 7,12-dimethylbenzanthracene-induced mouse mammary tumorigenesis
29. Erythrocyte selenium and breast cancer risk
30. Selenium in human mammary carcinogenesis: A case-referent study
31. Selenium in human mammary carcinogenesis: A case-cohort study
32. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination
33. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor
34. Vitamin supplements and cancer risk: Epidemiologic evidence
35. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
36. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor
37. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid
38. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue
39. Regulation of the estrogen receptor in MCF-7 cells by estradiol
40. Cancer mortality correlation studies - III: Statistical associations with dietary selenium intakes
41. Antioxidants and cancer. Part IV. Selenium and age-adjusted human cancer mortality
42. Arsenite and cadmium(II) as probes of glucocorticoid receptor structure and function
43. Activation of estrogen receptor-alpha by the heavy metal cadmium
44. The role of transforming growth factor-B in regulation of estrogen receptor expression in the MCF-7 breast cancer cell line
45. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domain
46. Selenium inhibition on N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat
47. Effect of short-term feeding of sodium selenite on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the rat
48. Selenium in diet, blood, and toenails in relation to breast cancer: A case-control study
49. Selenium and the risk of postmenopausal breast cancer in the DOM cohort
50. Cancer mortality in a residential cohort exposed to environmental selenium through drinking water
51. A structural role for hormone in the thyroid hormone receptor
52. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcriptional activation function
53. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast
54. A canonical structure for the ligand-binding domain of nuclear receptors
55. Selective effects of 8-Br-cAMP on agonists and antagonists of the glucocorticoid receptor
56. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer